| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.24B | — | +5.5% |
| Cost of Revenue | $274.3M | — | -1.5% |
| Gross Profit | $964.7M | — | +7.6% |
| R&D Expense | $227.9M | — | +11.0% |
| SG&A Expense | $96.3M | — | -5.9% |
| Operating Income | $310.5M | — | +28.5% |
| Pre-tax Income | $531.6M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $890.9M | -30.0% | -27.5% |
| Accounts Receivable | $467.8M | -5.9% | -2.0% |
| Current Assets | $8.58B | -1.0% | -1.1% |
| Total Assets | $12.16B | +1.7% | +11.0% |
| Current Liabilities | $2.03B | +1.6% | +7.1% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $521.6M | — | +6.6% |
| Capital Expenditures | $21.1M | — | -18.5% |
| Investing Cash Flow | -$480.7M | — | -284.2% |
| Financing Cash Flow | -$394.1M | — | +19.7% |
| Free Cash Flow | $500.5M | — | +8.0% |
| +68.4% |
| Income Tax | $105.9M | — | +73.2% |
| Net Income | $425.7M | — | +67.2% |
| EPS (Basic) | $1.45 | — | +72.6% |
| EPS (Diluted) | $1.42 | — | +75.3% |
| $2.19B |
| +1.8% |
| +6.9% |
| Stockholders' Equity | $9.97B | +1.7% | +12.0% |